Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University of Magdeburg, Magdeburg, Germany.
Gut. 2012 May;61(5):646-64. doi: 10.1136/gutjnl-2012-302084.
Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.
幽门螺杆菌感染的管理正在不断发展，在第 4 版马斯特里赫特共识报告中，2010 年再次审视了与幽门螺杆菌临床作用相关的方面。在第 4 次马斯特里赫特/佛罗伦萨共识会议上，来自 24 个国家的 44 名专家积极参与，并在三个分组研讨会上检查了关键的临床方面：（1）诊断和治疗的适应证和禁忌证，重点关注消化不良、非甾体抗炎药或阿司匹林使用、胃食管反流病和感染的肠外表现。（2）感染的诊断检测和治疗。（3）胃癌和其他并发症的预防。各个研讨会的结果提交给所有与会者进行最终共识投票。根据最佳现有证据和合理性提供建议，以指导涉及与各种临床情况相关的感染管理的医生。
